Fingerprint
Dive into the research topics of 'A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically